MENU
FHTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Foghorn Therapeutics (FHTX) Ownership - Who owns Foghorn Therapeutics?

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system... Show more

Profile

Industry
N/A
Address
99 Coolidge Avenue
Phone
+1 617 586-3100
Employees
106
Web
https://www.foghorntx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
219M
P/E Ratio
N/A
Total Cash
183.63M
Projected Growth
N/A
Total Debt
41.99M
Revenue
28.22M
Risk (Beta)
3.94
Dividend Yield
N/A
Total Cash/Share
3.13
Total Debt/Equity
N/A
Revenue/Share
0.44 USD as % of share price
View a ticker or compare two or three
FHTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
99 Coolidge Avenue
Phone
+1 617 586-3100
Employees
106
Web
https://www.foghorntx.com